XD-technology
is a concentrated fed-batch process that was patented by DSM Biologics and allows antibody concentrations in mammalian cells of 27 g L-1 at most to be reached. See ATF modules.
is a concentrated fed-batch process that was patented by DSM Biologics and allows antibody concentrations in mammalian cells of 27 g L-1 at most to be reached. See ATF modules.